Dr. Rebecca Cook holds a B.S. in Molecular & Cellular Biology from University of Arizona and a Ph.D. in Biological Design from Arizona State University. Since earning her bachelor’s degree in 2009, her research interests have been dedicated to cancer and neurological diseases. Her extensive experience spans high-throughput detection of single-nucleotide polymorphisms for genome-wide association studies, as well as the design and biological engineering of novel therapeutics that leverage the immune system and pathogen-derived proteins for targeted treatment of brain tumors and other neurological diseases. Her graduate research focused on the design, expression, and testing of a T cell-engaging fusion protein against glioblastoma. As a Post-Doctoral Fellow, and later as a Research Scientist at INanoBio Inc. and SPOC Proteomics, she has utilized her expertise in protein expression, interaction, and detection to explore innovative approaches for high-throughput biomarker screening for cancer and other diseases. Dr. Cook has played a key role as a project lead in the development and testing of SPOC Proteomics’ Protein Nanofactory System. As a Senior Research Scientist, she is responsible for the strategic design of nanowell/gene printing patterns, overseeing the production of protein biosensor chips on the protein nanofactory system, troubleshooting the system and sensor chip issues, optimizing and improving assays, and managing experimental designs for SPRi experiments.